Wuhan Daiwei Pharmaceutical Technology Co., Ltd. was established in October 2022. (formerly Shanghai Daiwei Chemical Technology Co., Ltd.) mainly provides high value-added and cost-effective products to domestic and foreign pharmaceutical research and development enterprises, biotechnology enterprises, university research institutions, and other customers, helping them shorten the research and development cycle and reduce research and production costs. The company's business focuses on complex indole, indole, azaindole series intermediates, API impurities, etc. After years of development and technological accumulation, the company now has a large number of high value-added spot products that meet the needs of various customers in a timely manner and have been recognized by a large number of customers. With the operation of the new research and development center, the company will enter a stage of rapid growth and will support customers' research and development projects with higher quality products and services.
Learn more
